Magenta Therapeutics magentatx.com


Public list: Pharma Startups (4733) Google In Healthcare (60)

Magenta Therapeutics (NASDAQ: MGTA) is a biotechnology company harnessing the power of stem cell science to revolutionize stem cell transplantation for patients with immune- and blood-based diseases. Magenta Therapeutics is working on an integrated, but modular approach to stem cell therapies that reboot the blood and immune systems to create patient benefit.

Magenta Therapeutics (NASDAQ: MGTA) is a biotechnology company harnessing the power of stem cell science to revolutionize stem cell transplantation for patients with immune- and blood-based diseases. Magenta Therapeutics is working on an integrated, ...Show all

Company (IPO / Went public)

Phone: 857-242-0170

Fax:

245 First Street

Cambridge, 02142
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Magenta Therapeutics $150.5M Apr 9, 2018

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Magenta Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 10 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Compositions and methods for the depletion of cd117+ cells Jun 19, 2017 Application